AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02507687 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimatoprost SR
Description: Bimatoprost SR is a biodegradable, sustained-release, preservative-free bimatoprost implant, preloaded in an applicator for administration. The Bimatoprost SR implant is injected into the anterior chamber via the corneal limbus using the prefilled applicator.
Study NCT02507687 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sham Bimatoprost SR
Description: Sham bimatoprost SR performed using the same procedure as for Bimatoprost SR using an needleless applicator that touches the eye at the area of insertion but does not deliver an implant into the anterior chamber.
Study NCT04373850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Visit
Description: Physical exam, medication dose titration
Study NCT04720950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 1 hour of exercise on a motorised treadmill at 70% maximal heart rate
Study NCT00729040 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stepping Up to Health
Description: Internet-mediated walking program with pedometers, goal-setting and tailored messaging
Study NCT00729040 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepping Up to Health
Description: Internet-mediated walking program with pedometers, goal-setting and tailored messaging
Study NCT01187264 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: once weekly for a total duration of 12 weeks or earlier till patient achieves PASI 75
Study NCT02515084 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET
Description: A FDG PET scan and a diffusion-weighted Magnetic Resonance Imaging will be performed to compare the efficacy to diagnose relapse in thyroid carcinoma
Study NCT02515084 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI imaging
Study NCT03863691 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amisulpride 300 MG
Description: A single dose of 300 mg amisulpride that looks identical to placebo control capsules.
Study NCT03863691 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: A placebo capsule with no inert pharmacological effect. Looks identical to the amisulpride capsules.
Study NCT00700154 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insulin infusion
Description: The infusion, a fast acting insulin analog in 1 Unit/ml of NaCl, starts prior the surgery the operation day for all patients and stops during the postoperative care in the control group (conventional therapy), the intervention group continues for three full days with insulin infusion. After the transition day (the fourth day) multiple doses of mixinsulin continues until the study ends 4 weeks after the randomization.
Study NCT00535392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Description: Intravenous 100 mg/mL, twice a day, maximum of 4 days~Subjects on oral levetiracetam at study entry receive the same intravenous (IV) dosage (mg-for-mg) to their oral dose.~Dosage for subjects not on levetiracetam at study entry was based on weight: if \<50 kg, the dose was 20 mg/kg/day (10 mg/kg/day twice daily); if weight ≥ 50 kg, the dose of levetiracetam intravenous (LEV IV) was 1000 mg/day (500 mg twice daily).
Study NCT03818555 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sebacia Microparticles Treatment
Description: Sebacia Microparticles procedure involving microparticles and 1064 nm laser. Three treatment procedures over a two-week period.
Study NCT03954717 — intervention group
Intervention type: BEHAVIORAL
Intervention: Shepherd CAN DO Program
Description: CAN DO Shepherd is a four-day participatory program held at the Shepherd Center, in Atlanta, Georgia or people with MS. The four-day program comprises evidence-based, comprehensive, and personalized educational and experiential opportunities aimed at empowering and enabling a person with MS to live a health life beyond their MS.
Study NCT02507687 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty
Description: SLT is a laser procedure that targets the melanin, or pigment, in specific cells of the eye.~An ophthalmologist performed 360 degrees of SLT using a standardized method.
Study NCT02507687 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sham Selective Laser Trabeculoplasty
Description: Sham SLT is performed on the contralateral eye using the same method as for SLT, with the exception that the laser is not switched to the active state.
Study NCT02331810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR113244
Description: Pharmaceutical form:solution for injection Route of administration: subcutaneous
Study NCT02331810 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Pharmaceutical form:solution for injection Route of administration: subcutaneous
Study NCT00088543 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]
Description: total dose 4.5 mg/kg
Study NCT00088543 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]
Description: total dose 8.5 mg/kg
Study NCT01049386 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No intervention
Description: In obese and lean subjects the intestinal absorption will be examined under normal conditions with sugar drink, and when disturbed by a high-fat breakfast.
Study NCT01049386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No intervention
Description: In obese and lean subjects the intestinal absorption will be examined under normal conditions with sugar drink, and when disturbed by a high-fat breakfast.
Study NCT01049386 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sugar absorption test
Description: On one of the test days the subjects will consume a high-fat breakfast.
Study NCT01049386 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sugar absorption test
Description: On one of the test days the subjects will consume a high-fat breakfast.
Study NCT02807961 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ELX-02
Description: Synthetic aminoglycoside
Study NCT02807961 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comparator
Study NCT01028755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY79-4620
Description: BAY79-4620 will be administered as 1 hour IV infusion. Dose escalation will be dependent on any dose limiting toxicities
Study NCT02668198 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Olympus CF190 Colonoscope High definition white light
Description: Standard endoscopic imaging technique
Study NCT02668198 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Olympus CF190 Colonoscope White light with near focus
Description: Near focus mode is used to closely examine the area of prior EMR site.
Study NCT02668198 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Olympus CF190 Colonoscope Narrow band imaging
Description: Narrow band imaging is utilized to examine the area of prior EMR.
Study NCT02668198 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Olympus CF190 Colonoscope Narrow band imaging with near focus
Description: NBI with near focus to help closely examine the area of prior EMR site.
Study NCT02668198 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Biopsy to assess any evidence of residual neoplasia via standard histopathology assessment
Study NCT01268098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NPSP558
Description: All patients will inject NPSP558 25 or 50 µg SC QD into alternating thighs in the morning via a multidose injection pen device.
Study NCT00817245 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: omeprazole, Amoxicillin, metronidazole
Description: we will evaluate the effect of medication(anti h.pylori) on the remission of ICSCR
Study NCT04219878 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Know@Home
Description: Participants randomly assigned to the Know@Home arm will access the features of Know@Home by downloading the app or accessing the website. The contents were developed to serve as a comprehensive mobile HIV prevention platform for MSM or TGW, with HIV prevention and care information and links to resources. This intervention arm provides an toolkit that allows users to access information about prevention services as their needs change. Participants will have access to Know@Home for the study period. The Know@Home arm will offer participants the opportunity to order free condoms and lubricant as well as an at-home sexually transmitted infection (STI) testing kit.
Study NCT04219878 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-test Kit
Description: All participants will be shipped two at-home HIV self-tests. They will also receive a link to a previously-produced video that fully describes the specimen collection process, pointing out common errors and providing tips for successful collection. Participants will interact with study staff through phone, email, or text. Information to schedule a video HIV testing and counseling session with study staff will be made available to participants in all arms via a website, email, and/or text.
Study NCT01584011 — intervention group
Intervention type: OTHER
Intervention: taste measurement
Description: Taste measurements with Electrogustometry and Filter paper test before and after surgery until one year after surgery
Study NCT01584011 — intervention group
Intervention type: OTHER
Intervention: Symptom questionnaire
Description: Answering a symptom questionnaire before and after surgery until one year after surgery
Study NCT01584011 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quality of life questionnaire
Description: Answering a quality of life questionnaire before and one year after surgery
Study NCT01584011 — intervention group
Intervention type: OTHER
Intervention: Nerve sample
Description: Collect nerve samples from patients undergoing surgery because of vestibular schwannoma, chronic otitis media or cholesteatoma where the nerve cant be saved during planned operation.
Study NCT03602248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Speed endurance training protocol A
Description: 1 set of 8 repetitions interspersed by 2,5 minutes of recovery with a work to rest ratio of 1:5 (25-30 seconds all out work)
Study NCT03602248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Speed endurance training protocol B
Description: 1 set of 8 repetitions interspersed by 4 minutes of recovery with a work to rest ratio of 1:8 (25-30 seconds all out work)
Study NCT03215342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pediatric Goal Management Training
Description: 7 GMT modules will be administered in 7x2 hours sessions (ten groups). Manualized intervention; metacognitive strategies for improving attention and problem solving. Homework assignments between sessions.
Study NCT03215342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pediatric Brain Health Workshop
Description: 7 pBHW modules will be administered in 7x2 hours sessions (ten groups). Psychoeducation; brain (dys)function, plasticity, memory, executive function, and attention. Stress, physical exercise, sleep, nutrition, and energy management. Homework assignments between sessions
Study NCT01722045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravitreal Aflibercept Injection (IAI)
Study NCT04332432 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: belapectin
Description: intravenous
Study NCT04505475 — intervention group
Intervention type: PROCEDURE
Intervention: Oral surgical procedure followed by local hemostatic measures (insertion of gelatine sponge and wound suturing)
Description: single and multiple teeth extraction, surgical tooth extraction, third molar surgery, gingivectomy, soft-tissue biopsy
Study NCT03921242 — intervention group
Intervention type: DRUG
Intervention: Metformin
Description: Newly Initiated and regular metformin dosage as prescribed by each patient's medical care provider
Study NCT03921242 — intervention group
Intervention type: DRUG
Intervention: Sulfonylurea
Description: Newly initiated and regular sulfonylurea dosage as prescribed by each patient's medical care provider
Study NCT03921242 — intervention group
Intervention type: DRUG
Intervention: DPP-4 inhibitor
Description: Newly initiated and regular DPP-4 inhibitor dosage as prescribed by each patient's medical care provider
Study NCT03921242 — intervention group
Intervention type: DRUG
Intervention: SGLT2 inhibitor
Description: Newly initiated and regular SGLT2 inhibitor dosage as prescribed by each patient's medical care provider
Study NCT03921242 — intervention group
Intervention type: DRUG
Intervention: GLP1 receptor agonist
Description: Newly initiated and regular GLP1 receptor agonist dosage as prescribed by each patient's medical care provider
Study NCT02990923 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-Flow Needleless Valve
Study NCT02990923 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DualCap Disinfection Devices
Study NCT01644188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab
Description: 1 mL subcutaneous injection in the abdomen, thigh, or outer area of the upper arm by self-injection or by another designated person using the autoinjector.
Study NCT01644188 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (for alirocumab)
Description: 1 mL subcutaneous injection in the abdomen, thigh, or outer area of the upper arm by self-injection or by another designated person using the autoinjector.
Study NCT01644188 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ezetimibe
Description: One over-encapsulated tablet orally once daily at approximately the same time of the day with or without food.
Study NCT01644188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (for ezetimibe)
Description: One capsule once daily orally at approximately the same time of the day with or without food.
Study NCT01644188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lipid Modifying Therapy (LMT)
Description: Statin (rosuvastatin, simvastatin or atorvastatin) at stable dose.
Study NCT01644188 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lipid Modifying Therapy (LMT)
Description: Statin (rosuvastatin, simvastatin or atorvastatin) at stable dose.
Study NCT02999737 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Platelet Rich Plasma for 4 sessions
Description: Injection of autologous platelet rich plasma into areas of alopecia on the scalp every month x 3 sessions then every 3 months x 1 session (total 4 sessions)
Study NCT02999737 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Platelet rich plasma for 2 sessions
Description: Injection of autologous platelet rich plasma into areas of alopecia on the scalp every 3 months x 2 sessions (total 2 sessions)
Study NCT04605198 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Mindfulness-based Stress Reduction
Description: Participants will be trained in mindfulness meditation and the applicability of mindfulness practices to daily life. During MBSR programming, teachers will lecture about key topics in mindfulness and lead class discussions. Participants are given homework assignments, such as listening to guided meditations. Participants are given opportunities to ask the instructor questions and to share their experiences with each other. Each session focuses on a different key topic. Topics are: Session 1: Introduction; Session 2: Understanding Perceptions; Session 3: Hatha Yoga, Sitting Meditation, Walking Meditation; Session 4: Concentration \& Awareness; Session 5: Unhealthy Patterns \&Getting Unstuck; Session 6: Transformational Coping Strategies; Session 7: Mini-retreat; Session 8: Maintaining Discipline \& Flexibility; Session 9: Course Review.
Study NCT04605198 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Promotion Wellness Classes
Description: Sessions will cover the following general wellness topics: Session 1; Introduction; Session 2: Envisioning Health Through Art; Session 3: Chronic Disease 1 (Heart Health); Session 4: Chronic Disease II (Diabetes); Session 5: Nutrition and Hydration; Session 6: Infectious Disease Prevention; Session 7: Skin Care; Session 8: Oral Health; Session 9: Promoting Social Integration \& Course Graduation.
Study NCT01042717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plerixafor
Description: Plerixafor administered at 16 hours prior to apheresis
Study NCT04224259 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound pre-scan
Description: Before cannulation, use ultrasound to mark the position of right internal jugular vein
Study NCT04224259 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Landmark guidance
Description: The traditional landmark-guided technique for internal jugular vein cannulation, including recognizing the sternocleidomastoid muscle and palpating the carotid artery
Study NCT04338230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercise
Description: Relaxation Exercises CD Audio Records prepared by Turkish Psychological Association is used. Before starting the PMR exercises, the woman in the intervention group is provided to lie on a comfortable seat or bed, stretching the muscles of the face and all body for about 10 seconds starting from the hands to the foot in line with the sound recordings of the PKG exercises and then holding the deep breath while each muscle group is stretching, It is applied as a slow release of this breath during relaxation. In this way, the muscle groups in the hands, arms, neck, shoulders, chest, abdomen, hips, feet and fingers, the face and the whole body are tensioned and relaxed, and the woman is relaxed. During the eight-week period, the women are called by the researcher once a week and the exercises are reminded. Home visit There are 2 home visits at week 1 and at week 8. In case of need, repeated home visits are provided to ensure the continuity of the application.
Study NCT01628406 — intervention group
Intervention type: PROCEDURE
Intervention: Treatment at the neurosurgery departement
Description: Treatment at the neurosurgery departement
Study NCT03181919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Letrozole is a third generation inhibitor that is emerging as a new oral agent for induction of ovulation.
Study NCT03479125 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Subjects will be observed to estimate the adjusted event rate for hepatocellular carcinoma with or without cirrhosis previously treated with emricasan or placebo.
Study NCT03477409 — intervention group
Intervention type: OTHER
Intervention: plasticizers
Description: The purpose of this biomonitoring study consists to evaluate the exposure of newborns and premature babies hospitalized in NICU to these plasticizers (DEHT and TOTM), by qualitative and quantitative measurement of their urinary metabolites
Study NCT02392663 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hypertonic saline solution
Description: All patients will perform 4 sessions during the same week. Each session will be include: inhalation period + bronchial drainage period. 20 minutes will be spent to perform the inhalation period. Moreover, 30 minutes will be spent to complete the bronchial drainage session post-inhalation.
Study NCT02392663 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hyaneb solution
Description: All patients will perform 4 sessions during the same week. Each session will be include: inhalation period + bronchial drainage period. 20 minutes will be spent to perform the inhalation period. Moreover, 30 minutes will be spent to complete the bronchial drainage session post-inhalation.
Study NCT02392663 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline solution
Description: All patients will perform 4 sessions during the same week. Each session will be include: inhalation period + bronchial drainage period. 20 minutes will be spent to perform the inhalation period. Moreover, 30 minutes will be spent to complete the bronchial drainage session post-inhalation.
Study NCT02371720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile DOT
Description: Daily reminders via text or email to send a video of themselves taking their Hydroxyurea, positive feedback, and be encouraged to contact the research coordinator with any questions, concerns, etc.
Study NCT02371720 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile DOT
Description: Daily reminders via text or email to send a video of themselves taking their Hydroxyurea, positive feedback, and be encouraged to contact the research coordinator with any questions, concerns, etc.
Study NCT01885923 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ITAREPS
Description: Program ITAREPS (Information Technology Aided Relaps Prevention in Schizophrenia)
Study NCT00003693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dolastatin 10
Description: IV bolus once every 3 weeks.
Study NCT01625676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Investigate efficacy of modified ciat schedule
Description: 2 hours of training over 15 days
Study NCT01625676 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: examine the efficacy of standard treatment versus modified ciat schedule
Description: 2 hours of training over 15 days
Study NCT03977571 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy
Description: Partial or complete nephrectomy by open, laparoscopic, or robotic approach.